To Get Help Now
Click Here
Today's Date:

New Jersey Plavix Lawsuits Centralized

AddThis Social Bookmark Button

The Supreme Court of New Jersey has issued an order to centralize all lawsuits filed throughout the state before Superior Court Judge Jessica R. Mayer in Middlesex. Bristol Myers Squibb Co., and Sanofi-Aventis requested mass tort designation, but were denied.

All of the Plavix lawsuits involved allege that Bristol Myers Squibb and Sanofi-Aventis failed to adequately research the medication, and failed to warn patients and physicians about the increased risks of side effects. According to the lawsuits, the companies were repeatedly cited by the FDA for illegal and off-label promotion, and for marketing campaigns that promoted the drug as better than aspirin and safer for the stomach.

Many of the lawsuit claim that Plavix was promoted the drug as a much safer alternative to aspirin, although there is no scientific proof that the expensive Plavix any benefit over the pennies-a-pill aspirin, in fact, several studies brought the safety and efficacy of the drug into doubt. As the result of the unnecessary use of Plavix, many plaintiffs have suffered serious and potentially life-threatening injury, including heart attack, stroke, thrombotic thrombocytopenic purpora, severe ulcers, and gastrointestinal bleeding.

The first case management conference will be held August 16, where attorneys will bring a list of all cases pending in state or federal courts, the status of discovery, and any settlement discussions that have occurred. disclaimer: This article: New Jersey Plavix Lawsuits Centralized was posted on Thursday, August 4th, 2011 at 7:10 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.